Financial Toxicity Among Caregivers of Patients With Cancer—An Increasing Problem Requiring Novel Solutions
Menée aux Etats-Unis par enquête auprès de 307 dyades constituées de patients ayant survécu à un cancer colorectal et de leurs conjoints, cette étude analyse l'association entre des difficultés financières et la qualité de vie des partenaires de vie
Advancements in modern clinical oncology have led to more advanced and personalized treatments, which in turn have led to higher costs that can have deleterious consequences. This unintended yet important aspect of cancer care, known as financial toxicity, has been associated with downstream ramifications, such as bankruptcy and early mortality.1 While many studies have looked at the differences in financial toxicity across demographic groups and cancer types, these analyses have been primarily limited to the patient; little is known about the prevalence and effects of financial toxicity on their partners and caregivers, whose support throughout the continuum of care is associated with demonstrably improved patient outcomes.
This mixed-methods survey study by Veenstra et al3 distinguishes itself by specifically focusing on the partners of survivors of cancer and how longitudinal financial toxicity impacts their health-related quality of life (HRQoL). By examining 307 partners of survivors of colorectal cancer (CRC), Veenstra et al3 found that the long-term financial toxicity among partners was associated with worse HRQoL across several domains, including pain, fatigue, sleep disturbance, and social functioning. (...)
JAMA Network Open , commentaire en libre accès, 2022